Emergent BioSolutions (EBS) Prelim. FY15 adj.-EPS Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- S&P 500 ends higher as investors await tech earnings
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year (2016-2020) Strategic Growth Plan
January 11, 2016 7:01 AM EST2015 Preliminary Estimates:Total revenues of $520 to $525 million, a 16% increase over 2014 (at midpoint)GAAP net income of $60 to $64 million, a 69% increase over 2014 (at midpoint)Adjusted net income of $73 to $77 million, a 38% increase over 2014 (at midpoint)EBITDA of $130 to $134 million, a 43% increase over 2014 (at midpoint)Year-end cash of approximately $310 million2016 Forecast:Total revenues of $600 to $630 millionGAAP net income of $75 to $85 millionAdjusted net income of $90 to $100 millionEBITDA of $150 to $160 million  2020 Key Financial and... More
